Ophthalmology – Homocystinuria Basics Description Homocystinuria comprises a group of inherited disorders of methionine metabolism characterized by excessive accumulation of homocysteine in the blood and urine. The classic and most common form is caused by deficiency of cystathionine β-synthase (CBS). Other metabolic defects causing homocystinuria include abnormalities of cobalamin metabolism and methylenetetrahydrofolate reductase (MTHFR) deficiency. Classic homocystinuria is a multisystem disorder affecting primarily the: Eyes Central nervous system Skeletal system Vascular system The hallmark ophthalmic manifestations are progressive high myopia and ectopia lentis. A major systemic danger is arterial and venous thromboembolism, which can cause stroke, pulmonary embolism, and premature death.

Epidemiology Classic homocystinuria is rare, although incidence varies substantially among populations because of founder mutations and consanguinity. Historically, the worldwide incidence has been estimated at approximately 1:200,000–300,000 live births, although biochemical and molecular screening suggests that it may be more common in some populations. Particularly high frequencies have been reported in Qatar and certain European populations.

Genetics Classic homocystinuria has autosomal recessive inheritance. It results from pathogenic variants in the CBS gene, located on chromosome 21q22.3. Many affected patients are compound heterozygotes, possessing two different pathogenic CBS variants. The particular variants and the amount of residual CBS enzyme activity influence disease severity and whether the patient responds to pyridoxine (vitamin B6).

Pathophysiology CBS normally participates in the transsulfuration pathway that converts homocysteine toward cysteine metabolism. CBS deficiency results in accumulation of: Homocysteine → homocystine → methionine with reduced downstream cysteine production. Elevated homocysteine has toxic effects on connective tissue and vascular endothelium. Ocularly, abnormal connective-tissue metabolism weakens the zonular fibers supporting the crystalline lens, eventually producing ectopia lentis. Systemically, increased endothelial dysfunction and platelet activation create a marked thrombotic tendency.

Ocular Manifestations Progressive Myopia Progressive myopia is often one of the earliest ophthalmic manifestations. Increasing lenticular myopia can precede obvious lens dislocation and may therefore provide an early clue to weakening of the zonules. A child developing unexplained rapidly progressive high myopia should be examined carefully for phacodonesis and early ectopia lentis.

Ectopia Lentis Ectopia lentis is the hallmark ocular abnormality of classic homocystinuria. It generally develops after infancy and becomes increasingly common with age. Progressive disruption of the zonular fibers causes the lens to become unstable and eventually subluxated or completely dislocated. Although traditionally described as inferonasal displacement, the lens in homocystinuria can actually dislocate in any direction. This is an important correction to the classic teaching.

Homocystinuria vs Marfan Syndrome Both disorders may produce a marfanoid body habitus and ectopia lentis, making differentiation particularly important. In homocystinuria, the zonular fibers tend to undergo degeneration and disruption, whereas in Marfan syndrome they are characteristically abnormal but may remain elongated. Classically: Homocystinuria → inferonasal lens displacement Marfan syndrome → superotemporal lens displacement However, lens direction alone should not be used to establish the diagnosis because homocystinuric lenses may dislocate in any direction. More useful distinguishing features are the presence in homocystinuria of developmental/intellectual impairment, osteoporosis, and especially thromboembolic disease.

Other Ocular Manifestations Additional ophthalmic abnormalities include: High myopia Irregular astigmatism Phacodonesis Cataract Pupillary-block glaucoma Retinal detachment Optic atrophy Staphyloma Amblyopia

Acute Pupillary-Block Glaucoma A markedly subluxated or dislocated lens may move anteriorly and obstruct aqueous flow through the pupil. This can cause acute pupillary-block glaucoma with: Severe ocular pain Red eye Blurred vision Markedly elevated intraocular pressure Corneal edema Possible nausea and vomiting This constitutes an ophthalmic emergency.

Systemic Manifestations Skeletal Findings Patients frequently develop a marfanoid habitus characterized by: Tall, thin stature Long extremities Scoliosis Pectus excavatum or carinatum Genu valgum Pes cavus High-arched palate Dental crowding Unlike Marfan syndrome, generalized osteoporosis is characteristic of homocystinuria.

Neurologic and Psychiatric Manifestations Neurologic manifestations vary considerably and may include: Developmental delay Intellectual disability Seizures Behavioral abnormalities Psychiatric disorders Importantly, early metabolic treatment can substantially modify neurologic outcome.

Thromboembolic Disease Thromboembolism is the major life-threatening complication of classic homocystinuria. Both arteries and veins may be affected. Complications include: Ischemic stroke Cerebral venous thrombosis Deep-vein thrombosis Pulmonary embolism Peripheral arterial thrombosis Other organ ischemia Thrombosis may occur spontaneously or be precipitated by dehydration, prolonged immobilization, surgery, anesthesia, or other physiologic stresses. This risk is particularly important when planning ocular surgery.

Diagnosis History Important questions include: Birth and Screening History Determine whether newborn metabolic screening was performed and whether abnormalities were detected. Developmental History Ask about: Speech delay Developmental delay Learning difficulties Behavioral or psychiatric abnormalities Family History Important clues include: Consanguinity Similarly affected siblings Unexplained thrombosis Stroke or thromboembolic death at a young age Ocular History Ask about: Progressive myopia Frequent spectacle changes Poor vision Monocular visual preference Ocular pain or redness Previous lens dislocation

Physical Examination General Examination Look for: Marfanoid habitus Scoliosis Pectus deformity Genu valgum Pes cavus High-arched palate Dental crowding Malar flushing Osteoporosis or history of fractures Neurologic and developmental assessment should also be performed. Ophthalmic Examination A comprehensive examination should include: Visual acuity Cycloplegic refraction in children Slit-lamp examination Intraocular pressure Assessment for phacodonesis Lens position Dilated retinal examination Particular attention should be directed toward progressive high myopia and ectopia lentis.

Diagnostic Tests Biochemical Testing Classic CBS deficiency typically produces: Markedly elevated plasma total homocysteine and usually: Elevated plasma methionine Urinary homocystine may also be elevated. Modern diagnosis relies principally on quantitative plasma amino acids, plasma total homocysteine, biochemical enzyme assessment when required, and molecular genetic testing.

Newborn Screening Newborn screening traditionally detects classic homocystinuria through elevated methionine. However, screening can miss affected infants, particularly those whose methionine concentration has not risen sufficiently when the specimen is obtained. Thus, a normal newborn screen does not absolutely exclude homocystinuria when later clinical findings are strongly suggestive.

Molecular Genetic Testing Molecular analysis of the CBS gene can confirm the diagnosis and identify the causative variants. Genetic testing is also valuable for: Family screening Carrier identification Genetic counseling Prenatal or preimplantation genetic testing when familial pathogenic variants are known

Pyridoxine Responsiveness An important component of metabolic evaluation is determining whether the patient responds to pyridoxine (vitamin B6). CBS uses pyridoxal phosphate, derived from vitamin B6, as a cofactor. Some pathogenic variants leave sufficient residual enzyme activity that pharmacologic pyridoxine substantially lowers homocysteine concentrations. Patients are therefore broadly classified as: B6-responsive or B6-nonresponsive. Responsiveness has important implications for both treatment and prognosis. High-dose pyridoxine testing and therapy should be conducted under specialist metabolic supervision because excessive doses can cause serious toxicity.

Imaging and Additional Testing Brain MRI with appropriate vascular/stroke imaging should be obtained when focal neurologic findings suggest cerebrovascular disease. DEXA scanning may be used to assess and monitor osteoporosis. Ocular imaging such as anterior-segment OCT or ultrasound biomicroscopy can occasionally help characterize severe lens displacement, although the diagnosis of ectopia lentis is usually clinical.

Differential Diagnosis Important causes of ectopia lentis include: Marfan syndrome Weill–Marchesani syndrome Familial isolated ectopia lentis Ectopia lentis et pupillae Trauma Aniridia Ocular coloboma Microspherophakia Sulfite oxidase deficiency Molybdenum cofactor deficiency Other metabolic causes of elevated homocysteine, particularly remethylation disorders such as MTHFR and cobalamin-related defects, must also be distinguished from classic CBS deficiency.

Treatment Treatment should be coordinated with a metabolic disease specialist. The principal objective is sustained reduction of plasma homocysteine to decrease the risk of thromboembolic and other systemic complications.

Pyridoxine Patients who demonstrate pyridoxine responsiveness are treated with vitamin B6, with dosage individualized by the metabolic specialist according to biochemical response. Folate and vitamin B12 status should be optimized because deficiencies can further impair homocysteine metabolism.

Dietary Therapy Patients who are insufficiently responsive to pyridoxine generally require a methionine-restricted diet. Specialized amino-acid preparations may be required to maintain adequate nutrition while restricting methionine. Dietary treatment should be managed by a metabolic dietitian because excessive protein restriction can adversely affect growth and development.

Betaine Betaine promotes remethylation of homocysteine to methionine and can substantially reduce plasma homocysteine concentrations. It is particularly useful when pyridoxine and dietary treatment do not achieve adequate biochemical control. Because betaine can increase methionine concentrations, biochemical monitoring remains important.

Ophthalmic Treatment Refractive Correction Myopia and astigmatism should be corrected promptly using: Spectacles Contact lenses when appropriate Children require careful monitoring for anisometropic or deprivation amblyopia. Amblyopia Amblyopia should be treated aggressively during the visual-development period with appropriate optical correction and, when indicated, patching or pharmacologic penalization.

Lens Surgery Lens extraction may be necessary when ectopia lentis causes: Uncorrectable visual impairment Severe progressive refractive error Amblyogenic optical distortion Lens-induced inflammation Pupillary-block glaucoma Complete lens dislocation Other significant complications Modern surgical technique is individualized according to the degree of zonular instability and associated ocular anatomy.

Perioperative Considerations Surgery in a patient with homocystinuria requires special planning because of the marked risk of perioperative thrombosis. Before elective ocular or systemic surgery, coordination with metabolic medicine, anesthesia, hematology, and the surgical team is appropriate. Important measures include: Maintaining adequate hydration Avoiding prolonged immobilization Maintaining metabolic control Assessing individual thrombosis risk Using thromboprophylaxis when indicated by the treating team The thromboembolic risk may be more clinically consequential than the ocular procedure itself.

Ongoing Care Patients require multidisciplinary lifelong follow-up involving: Ophthalmology Metabolic medicine Primary care/pediatrics Nutrition Genetics Hematology when appropriate Neurology when cerebrovascular or neurologic disease is present Ophthalmic monitoring should assess: Refraction Lens stability Intraocular pressure Amblyopia Retinal status Visual function

Patient Education Patients and families should understand the importance of lifelong metabolic treatment, even when the patient feels well. They should recognize symptoms potentially indicating thrombosis or stroke and seek emergency medical evaluation when these occur. Genetic counseling is appropriate because classic CBS-deficiency homocystinuria is autosomal recessive.

Prognosis Prognosis depends strongly on how early the disorder is recognized and how effectively homocysteine concentrations are controlled. Early treatment can markedly reduce systemic complications and may prevent or delay developmental impairment and ectopia lentis. Untreated disease carries a substantial risk of progressive ocular abnormalities, neurologic impairment, osteoporosis, and potentially fatal thromboembolism.

Complications Major complications include: Ectopia lentis Severe myopia Amblyopia Cataract Pupillary-block glaucoma Retinal detachment Optic atrophy Osteoporosis and fractures Developmental and neuropsychiatric impairment Arterial and venous thromboembolism Stroke Pulmonary embolism Premature death

High-Yield Clinical Pearls Homocystinuria + ectopia lentis + marfanoid habitus + developmental abnormalities + thrombosis = classic CBS deficiency until proven otherwise. The most dangerous complication is thromboembolism. The major ophthalmic clue is progressive myopia followed by ectopia lentis. Unlike traditional teaching, the lens in homocystinuria can dislocate in any direction. Homocystinuria vs Marfan: think thrombosis, developmental impairment, osteoporosis, and disrupted zonules in homocystinuria. Early diagnosis and metabolic treatment can prevent major ocular and systemic morbidity.